Funding for this research was provided by:
Deutsches Zentrum für Diabetesforschung
Deutsche Forschungsgemeinschaft (Projektnummer 209933838 – SFB 1052; B03, Projektnummer 209933838 – SFB 1052; B08)
Deutsche Forschungsgemeinschaft (Projektnummer 209933838 – SFB 1052; C1)
Bundesministerium für Bildung und Forschung (FKZ: 01EO1501; AD2-060E, AD2-06E95, K7-117, FKZ: 01EO1501; ADI-K7-39, ADI-K50D, FKZ: 01EO1501; AD2-7123, AD2-7118)
Israel Science Foundation
Ministry of Science and Technology, Israel (grant # 3-13604)
Dr. Robert C. and Veronica Atkins Foundation
Received: 15 April 2020
Accepted: 27 October 2020
First Online: 16 November 2020
Ethics approval and consent to participate
: The study was conducted in accordance with the Declaration of Helsinki, and the protocol for the exploratory analyses was approved by the Medical Ethics Board and Institutional Review Board at Soroka University Medical Center, Be’er Sheva, Israel (0239-11SOR). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.